Genomize is an established global bioinformatics company founded in 2014 which specializes in the analysis of genomic data. Adopting quality and customer-orientation as main principles, Genomize delivers its diverse academic assets to its customers accurately, rapidly and reliably. Genomize's SEQ platform focuses on the analysis of Next Generation Sequencing (NGS) data. SEQ provides a full-fletch solution from raw data to clinical report generation, automates data transfer and back-up, offers tools for data and organization management, provides detailed bioinformatics analysis, and enables users to access these from any device connected to the internet. SEQ platform is being actively used by hospitals, genetic diagnosis centers, and research institutes, whose focus is analysis of NGS data. The company processed more than 200,000 samples from more than 300 centers in more than 20 countries count SEQ as their core bioinformatics solution.
Looking for a particular Genomize employee's phone or email?
The Genomize annual revenue was $5 million in 2026.
Ersen Kavak is the Founder and Manager of Genomize.
15 people are employed at Genomize.
The NAICS codes for Genomize are [54171, 5417, 541, 541713, 54].
The SIC codes for Genomize are [873, 87].